PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12063468-0	2002	Antisense therapy for malignant mesothelioma with oligonucleotides targeting the bcl-xl gene product.	Oligonucleotides	50-66	BCL2 like 1	Homo sapiens	81-87	
12063468-6	2002	Untreated cells and bcl-xl sense oligonucleotides were controls.	Oligonucleotides	33-49	BCL2 like 1	Homo sapiens	20-26	
12063468-8	2002	RESULTS: Bcl-xl protein expression after antisense oligonucleotides was downwardly regulated in both cell lines relative to sense oligonucleotides (>65%).	Oligonucleotides	51-67	BCL2 like 1	Homo sapiens	9-15	
12063468-8	2002	RESULTS: Bcl-xl protein expression after antisense oligonucleotides was downwardly regulated in both cell lines relative to sense oligonucleotides (>65%).	Oligonucleotides	130-146	BCL2 like 1	Homo sapiens	9-15	
12063468-12	2002	CONCLUSION: Antisense oligonucleotides directed at the bcl-xl gene product engender apoptosis in mesothelioma cell lines.	Oligonucleotides	22-38	BCL2 like 1	Homo sapiens	55-61